Literature DB >> 15853524

Recent advances in the neuropathology of focal lesions in epilepsy.

Maria Thom1.   

Abstract

This review addresses the main neuropathologic advances that have been made over recent years in the study of focal lesions in patients with epilepsy undergoing surgical treatment. There have been revisions and simplifications to the classification of focal cortical dysplasias. Hippocampal sclerosis is a well-characterized lesion but further pathologic studies have explored its possible relationship to temporal lobe developmental lesions, ongoing neurogenesis and mechanisms of its epileptogenicity. The important contribution of astrocytes to epileptogenesis is also unfolding and is briefly discussed, as are the possible cellular mechanisms of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15853524     DOI: 10.1586/14737175.4.6.973

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  14 in total

1.  Inhibition of miR-181a-5p reduces astrocyte and microglia activation and oxidative stress by activating SIRT1 in immature rats with epilepsy.

Authors:  Huimin Kong; Huaili Wang; Zhihong Zhuo; Zhenbiao Li; Peichao Tian; Jing Wu; Jian Liu; Zheng Chen; Jiyao Zhang; Qiang Luo
Journal:  Lab Invest       Date:  2020-05-27       Impact factor: 5.662

2.  SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Authors:  Sierk Haenisch; Yi Zhao; Aparna Chhibber; Kitti Kaiboriboon; Lynn V Do; Silke Vogelgesang; Nicholas M Barbaro; Brian K Alldredge; Daniel H Lowenstein; Ingolf Cascorbi; Deanna L Kroetz
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

Review 3.  Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders?

Authors:  Maria Vincenza Catania; Simona D'Antoni; Carmela Maria Bonaccorso; Eleonora Aronica; Mark F Bear; Ferdinando Nicoletti
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

4.  Focal epilepsy associated with glioneuronal tumors.

Authors:  Giulia Loiacono; Chiara Cirillo; Francesco Chiarelli; Alberto Verrotti
Journal:  ISRN Neurol       Date:  2011-07-07

5.  Genome-wide microRNA profiling of rat hippocampus after status epilepticus induced by amygdala stimulation identifies modulators of neuronal apoptosis.

Authors:  Zhen Sun; Jin-Tai Yu; Teng Jiang; Meng-Meng Li; Lin Tan; Qun Zhang; Lan Tan
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

6.  Mapping of cognitive functions in chronic intractable epilepsy: Role of fMRI.

Authors:  Kapil Chaudhary; S Senthil Kumaran; Sarat P Chandra; Ashima Nehra Wadhawan; Manjari Tripathi
Journal:  Indian J Radiol Imaging       Date:  2014-01

7.  Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy.

Authors:  Fang He; Bei Liu; Qiang Meng; Yang Sun; Weiwen Wang; Chao Wang
Journal:  Biosci Rep       Date:  2016-12-23       Impact factor: 3.840

8.  Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB.

Authors:  Karin Boer; Dirk Troost; Wim G M Spliet; Peter C van Rijen; Jan A Gorter; Eleonora Aronica
Journal:  Acta Neuropathol       Date:  2008-03-04       Impact factor: 17.088

Review 9.  MicroRNA regulation and dysregulation in epilepsy.

Authors:  Danyella B Dogini; Simoni H Avansini; Andre S Vieira; Iscia Lopes-Cendes
Journal:  Front Cell Neurosci       Date:  2013-10-04       Impact factor: 5.505

10.  Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis - Influence on microglial function.

Authors:  Bénédicte Danis; Marijke van Rikxoort; Anita Kretschmann; Jiong Zhang; Patrice Godard; Lidija Andonovic; Franziska Siegel; Pitt Niehusmann; Etienne Hanon; Daniel Delev; Marec von Lehe; Rafal M Kaminski; Alexander Pfeifer; Patrik Foerch
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.